Literature DB >> 9600487

Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials.

C L Meinert1.   

Abstract

Mesh：

Year:  1998        PMID： 9600487     DOI： 10.1001/jama.279.18.1487

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  David Moher; Kenneth F Schulz; Douglas G Altman
Journal:  Clin Oral Investig       Date:  2003-01-31       Impact factor: 3.573

2.  Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery.

Authors:  Elena Losina; James Wright; Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2012-03-21       Impact factor: 5.284

3.  Achieving high research reporting quality through the use of computational ontologies.

Authors:  Amrapali Zaveri; Luciana Cofiel; Jatin Shah; Shreyasee Pradhan; Edwin Chan; Olivier Dameron; Ricardo Pietrobon; Beng Ti Ang
Journal:  Neuroinformatics       Date:  2010-12

4.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 5.  [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

6.  Screen failure data in clinical trials: Are screening logs worth it?

Authors:  Jordan J Elm; Yuko Palesch; J Donald Easton; Anne Lindblad; William Barsan; Robert Silbergleit; Robin Conwit; Catherine Dillon; Mary Farrant; Holly Battenhouse; Aaron Perlmutter; S Claiborne Johnston
Journal:  Clin Trials       Date:  2014-06-12       Impact factor: 2.486

Review 7.  OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis.

Authors:  E Losina; J Ranstam; J E Collins; T J Schnitzer; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2015-05       Impact factor: 6.576

8.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  BMC Med Res Methodol       Date:  2001-04-20       Impact factor: 4.615

9.  Guidance for developers of health research reporting guidelines.

Authors:  David Moher; Kenneth F Schulz; Iveta Simera; Douglas G Altman
Journal:  PLoS Med       Date:  2010-02-16       Impact factor: 11.069

10.  Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data.

Authors:  Charla Nich; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.